Joseph Maroon - Mylan N Insider

Mylan N V -- USA Stock  

USD 46.64  0.26  0.55%

Independent Director

Dr. Joseph C. Maroon, M.D., is an Independent Director of Mylan Inc., since 2003. Dr. Maroon is currently Professor, Heindl Scholar in Neuroscience and Vice Chairman of the Department of Neurosurgery, University of Pittsburgh Medical Center, and has held other positions at UPMC since 1998. He has also served as the team neurosurgeon for the Pittsburgh Steelers since 1981. From 1995 to 1998, Dr. Maroon was Professor and Chairman of the Department of Surgery at Allegheny General Hospital, and from 1984 to 1999 he was Professor and Chairman of the Department of Neurosurgery at Allegheny General Hospital. Dr. Maroon has earned numerous awards for his contributions to neurosurgery from various national and international neurological societies throughout his career, and patients travel from all over the world to seek his care.
Age: 73  Director Since 2003      
44 1707 853000  http://www.mylan.com

Joseph Maroon Latest Insider Activity

Management Efficiency

The company has Return on Asset of 3.79 % which means that on every $100 spent on asset it made $3.79 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 6.92 % implying that it generated $6.92 on every 100 dollars invested.
The company has 14.72 B in debt with debt to equity (D/E) ratio of 110.7 . This implies that the company may be unable to create cash to meet all of its financial commitments. Mylan N V has Current Ratio of 1.43 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives

DIRECTOR Since

Glenn TiltonAbbott Laboratories
2007
John StrattonAbbott Laboratories
2017
Phebe NovakovicAbbott Laboratories
2010
William SpenglerEndo International plc
2008
Jill SmithEndo International plc
2012
Nancy HutsonEndo International plc
2009
Todd SisitskyEndo International plc
2016
Sangeeta BhatiaVertex Pharmaceuticals Incorpor
2015
Michael HyattEndo International plc
N/A
Yuchun LeeVertex Pharmaceuticals Incorpor
2012
Deborah NeffBio Rad Laboratories Inc
2011
Joel McCombBio Rad Laboratories Inc
2014
Bruce SachsVertex Pharmaceuticals Incorpor
2017
David GreenwayVertex Pharmaceuticals Incorpor
2017
Sharad MansukaniEndo International plc
2017
William OsbornAbbott Laboratories
2013
Samuel ScottAbbott Laboratories
2007
Arthur HigginsEndo International plc
2013
James FarrellAbbott Laboratories
2006
Louis DrapeauBio Rad Laboratories Inc
2007
Elaine UllianVertex Pharmaceuticals Incorpor
2011

Entity Summary

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. Mylan N V (MYL) is traded on NASDAQ in USA. It is located in UNITED KINGDOM and employs 35,000 people. Mylan N is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Bollinger Bands Now
   

Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
Hide  View All  NextLaunch Bollinger Bands
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Mylan N V to your portfolio

Top Management

Mylan N V Leadership Team
Anthony Mauro, President
Joseph Maroon, Director
Kris King, VP
Heather Bresch, CEO
Melina Higgins, Director
Mark Parrish, Director
Kenneth Parks, CFO
Rodney Piatt, Chairman, CPA
Rajiv Malik, President
John Sheehan, President, CPA
Dennis Zeleny, Executive
JoEllen Dillon, Director
Neil Dimick, Director
Sjoerd Vollebregt, Director
Douglas Leech, Director
Robert Cindrich, Director
Wendy Cameron, Director
Rakesh Bamzai, President, MBA
Robert Coury, Chairman
Daniel Gallagher, Executive
Randall Vanderveen, Director

Stock Performance

Mylan N Performance Indicators